Meisamy Sina, Bolan Patrick J, Baker Eva H, Pollema Matthew G, Le Chap T, Kelcz Frederick, Lechner Mary C, Luikens Barbara A, Carlson Richard A, Brandt Kathy R, Amrami Kimberly K, Nelson Michael T, Everson Lenore I, Emory Tim H, Tuttle Todd M, Yee Douglas, Garwood Michael
Department of Radiology, Center for Magnetic Resonance Research Medical School, 2021 Sixth St SE, Minneapolis, MN 55455, USA.
Radiology. 2005 Aug;236(2):465-75. doi: 10.1148/radiol.2362040836.
To determine whether the addition of in vivo quantitative hydrogen 1 (1H) magnetic resonance (MR) spectroscopy can improve the radiologist's diagnostic accuracy in interpreting breast MR images to distinguish benign from malignant lesions.
The study was approved by the institutional review board and, where appropriate, was compliant with the Health Insurance Portability and Accountability Act. All patients provided written informed consent. Fifty-five breast MR imaging cases-one lesion each in 55 patients aged 24-66 years with biopsy-confirmed findings-were retrospectively evaluated by four radiologists. Patients were examined with contrast material-enhanced fat-suppressed T1-weighted 4.0-T MR imaging. The concentration of total choline-containing compounds (tCho) was quantified by using single-voxel 1H MR spectroscopy. For each case, the radiologists were asked to give the percentage probability of malignancy, the Breast Imaging and Reporting Data System category, and a recommendation for patient treatment. Two interpretations were performed for each case: The initial interpretation was based on the lesion's morphologic features and time-signal intensity curve, and the second interpretation was based on the lesion's morphologic features, time-signal intensity curve, and tCho concentration. Receiver operating characteristic (ROC), Wilcoxon signed rank, kappa statistic, and accuracy (based on the area under the ROC curve) analyses were performed.
Of the 55 lesions evaluated, 35 were invasive carcinomas and 20 were benign. The addition of 1H MR spectroscopy resulted in higher sensitivity, specificity, accuracy, and interobserver agreement for all four radiologists. More specifically, two of the four radiologists achieved a significant improvement in sensitivity (P=.03, P=.03), and all four radiologists achieved a significant improvement in accuracy (P = .01, P = .05, P = .009, P < .001).
Current study results suggest that the addition of quantitative 1H MR spectroscopy to the breast MR imaging examination may help to improve the radiologist's ability to distinguish benign from malignant breast lesions.
确定添加体内定量氢1(1H)磁共振(MR)波谱是否能提高放射科医生解读乳腺MR图像以区分良性与恶性病变的诊断准确性。
本研究经机构审查委员会批准,并在适当情况下符合《健康保险流通与责任法案》。所有患者均提供了书面知情同意书。对55例乳腺MR成像病例进行回顾性评估,这些病例来自年龄在24 - 66岁的55例患者,每人有一个病变,活检结果已得到证实,由四位放射科医生进行评估。患者接受了对比剂增强脂肪抑制T1加权4.0-T MR成像检查。使用单体素1H MR波谱对总含胆碱化合物(tCho)的浓度进行定量。对于每个病例,要求放射科医生给出恶性肿瘤的百分比概率、乳腺影像报告和数据系统分类以及对患者治疗的建议。每个病例进行两次解读:初始解读基于病变的形态特征和时间 - 信号强度曲线,第二次解读基于病变的形态特征、时间 - 信号强度曲线和tCho浓度。进行了受试者操作特征(ROC)、Wilcoxon符号秩、kappa统计和准确性(基于ROC曲线下面积)分析。
在评估的55个病变中,35个为浸润性癌,20个为良性。添加1H MR波谱后,四位放射科医生的敏感性、特异性、准确性和观察者间一致性均有所提高。更具体地说,四位放射科医生中有两位的敏感性有显著提高(P = 0.03,P = 0.03),所有四位放射科医生的准确性均有显著提高(P = 0.01,P = 0.05,P = 0.009,P < 0.001)。
当前研究结果表明,在乳腺MR成像检查中添加定量1H MR波谱可能有助于提高放射科医生区分乳腺良性与恶性病变的能力。